Four-year review of presenteeism data among employees of a large United States health care system: a retrospective prevalence study

Allen, Donna; Hines, Erica Wandtke; Pazdernik, Vanessa; Konecny, Lynda; Breitenbach, Erin

doi:10.1186/s12960-018-0321-9

Cited by 83 publications

(71 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Despite the potential time commitment involved in dialysis and/or in transplantation, there has been limited evidence with respect to estimation of productivity losses associated with RRT. Similarly, while previous research has documented the relationship between dialysis and depression [97], and the potential impact of depression on productivity [98], there is also a gap in research examining the impact of comorbidities on the productivity of ESRD patients.…”

Section: Plos Onementioning

confidence: 99%

The impact of chronic kidney disease on developed countries from a health economics perspective: A systematic scoping review

et al. 2020

View full text Add to dashboard Cite

Chronic kidney disease (CKD) affects over 10% of the global population and poses significant challenges for societies and health care systems worldwide. To illustrate these challenges and inform cost-effectiveness analyses, we undertook a comprehensive systematic scoping review that explored costs, health-related quality of life (HRQoL) and life expectancy (LE) amongst individuals with CKD. Costs were examined from a health system and societal perspective, and HRQoL was assessed from a societal and patient perspective. Papers published in English from 2015 onward found through a systematic search strategy formed the basis of the review. All costs were adjusted for inflation and expressed in US$ after correcting for purchasing power parity. From the health system perspective, progression from CKD stages 1-2 to CKD stages 3a-3b was associated with a 1.1-1.7 fold increase in per patient mean annual health care cost. The progression from CKD stage 3 to CKD stages 4-5 was associated with a 1.3-4.2 fold increase in costs, with the highest costs associated with end-stage renal disease at $20,110 to $100,593 per patient. Mean EuroQol-5D index scores ranged from 0.80 to 0.86 for CKD stages 1-3, and decreased to 0.73-0.79 for CKD stages 4-5. For treatment with renal replacement therapy, transplant recipients incurred lower costs and demonstrated higher HRQoL scores with longer LE compared to dialysis patients. The study has provided a comprehensive updated overview of the burden associated with different CKD stages and renal replacement therapy modalities across developed countries. These data will be useful for the assessment of new renal services/ therapies in terms of cost-effectiveness.

show abstract

Section: Plos Onementioning

confidence: 99%

The impact of chronic kidney disease on developed countries from a health economics perspective: A systematic scoping review

et al. 2020

View full text Add to dashboard Cite

show abstract

“…7,8 MDD is associated both with having to take time off work (absenteeism) and with reduced productivity when at work (presenteeism), 9 and its impact on the ability to work and work productivity appears greater than that of other common mental and physical health disorders. [10][11][12] Indeed, reduced work productivity accounts for the majority of the financial costs attributed to MDD. 10,13 Cognitive symptoms are common in patients with MDD, with deficits observed across multiple domains (eg, executive function, memory, and attention).…”

Section: Introductionmentioning

confidence: 99%

<p>Impact of Cognitive Symptoms on Health-Related Quality of Life and Work Productivity in Chinese Patients with Major Depressive Disorder: Results from the PROACT Study</p>

Wang¹,

Tan²,

Ren³

et al. 2020

NDT

View full text Add to dashboard Cite

Purpose: This post hoc analysis was undertaken to further explore the association of cognitive symptoms with health-related quality of life (HRQoL) and work productivity at the time of treatment initiation in Chinese patients with major depressive disorder (MDD) in the Prospective Research Observation to Assess Cognition in Treated patients with MDD (PROACT) study. Patients and Methods: This was an epidemiological, non-interventional, prospective cohort study in adult outpatients with moderate-to-severe MDD initiating antidepressant monotherapy (first or second line). Crude and adjusted analyses of covariance were performed to assess the association of perceived cognitive symptoms (20-item Perceived Deficits Questionnaire-Depression [PDQ-D] total score) or observed cognitive performance (Digit Symbol Substitution Test [DSST] score) with HRQoL (EuroQoL 5-Dimensions Questionnaire index) and work productivity (Work Productivity and Activity Impairment [WPAI] or Sheehan Disability Scale [SDS] absenteeism and presenteeism scores). Adjusted analyses included depression severity, age, sex, residential area (urban/rural), and educational level. Results: Of 1008 patients enrolled in the PROACT study, 986 were included in this analysis. Severity of perceived cognitive symptoms (ie, higher PDQ-D total score) was significantly associated with worse HRQoL (P<0.001) and higher levels of absenteeism (P=0.020 for the WPAI and P=0.002 for the SDS) and presenteeism (P<0.001 for both scales). The association of perceived cognitive symptoms with HRQoL and presenteeism was independent of depression severity. The association between observed cognitive performance (DSST score) and HRQoL was less robust. No association was seen between observed cognitive performance and levels of absenteeism or presenteeism assessed by either scale. Conclusion: Results of this real-world study illustrate the impact of cognitive symptoms on HRQoL and work productivity in Chinese patients with MDD, and highlight the importance of assessing and targeting cognitive symptoms in order to improve functional outcomes when treating patients with MDD.

show abstract

“…However, these rising costs of healthcare employees increase the direct cost burden of the medical health system and presentism is a relevant factor in this context. Presenteeism, which is commonly referred to as an employee at work who has impaired productivity due to health considerations, has been identified as an indirect but relevant factor influencing productivity and human capitol ( 39 ). Especially in psychiatry the human capitol is necessary to help patients, to be optimistic, to build constructive therapeutic relationships and to prevent patients from fatal complications.…”

Section: Discussionmentioning

confidence: 99%

A Two-Day Acceptance and Commitment Therapy (ACT) Workshop Increases Presence and Work Functioning in Healthcare Workers

et al. 2020

View full text Add to dashboard Cite

Background In this controlled naturalistic study performed in healthcare workers we examined the effect of a two-day acceptance commitment therapy (ACT) workshop on work presence and productivity, i.e. the influence the workshop had on treatment efficacy in a routine hospital care setting. Aim To examine the influence of ACT on productivity and presence in healthcare workers. Method Study participants were all healthcare workers (nurses, medical doctors, physiotherapists, social workers, and art therapists) of four inpatient wards for depression. Half of the healthcare workers attended the workshop. Measures were evaluated 3 months after the intervention in the study participants and the patients treated by them in the same time period. Results A significantly higher treatment efficacy [as measured with HoNOS (Health of the nation outcome scales) change in the patients treated by the participants] has been observed in the healthcare workers who attended the ACT workshop when compared to the control group who did not attend the workshop. Moreover, the work presence of the participants of the ACT workshop was increased when compared with the time period before the intervention and with the presence of the control group. A cost analysis showed that ACT workshops lead to a significant return of investment for the employer as the costs for the workshop were ten times compensated by the increase of work presence in participants of the workshop. Conclusion These findings provide support that ACT interventions motivate healthcare workers to work and increase their patients’ treatment quality. To our knowledge this is the first study showing an ACT workshop in healthcare workers can influence HoNOS outcome in the treated patients.

show abstract

Four-year review of presenteeism data among employees of a large United States health care system: a retrospective prevalence study

Cited by 83 publications

References 13 publications

The impact of chronic kidney disease on developed countries from a health economics perspective: A systematic scoping review

The impact of chronic kidney disease on developed countries from a health economics perspective: A systematic scoping review

<p>Impact of Cognitive Symptoms on Health-Related Quality of Life and Work Productivity in Chinese Patients with Major Depressive Disorder: Results from the PROACT Study</p>

A Two-Day Acceptance and Commitment Therapy (ACT) Workshop Increases Presence and Work Functioning in Healthcare Workers

Contact Info

Product

Resources

About